• Latest News

Almac Group Donates a Quarter of a Million Pounds to Global Charities in Wake of COVID-19

Employee-driven initiative will benefit 33 health and welfare organisations local to Almac’s 11 global facilities Craigavon, Northern Ireland - 02 September 2020 – Almac Group has today announced the organisation will donate £250,000 to 33 charities globally to support their critical work in the wake of COVID-19. Each year Almac hosts a...

Read more

Announcing the Winner of the Dr John Hinds Scholarship Award 2020

Craigavon, U.K. – 16 Jun 2020 - Today, the College of Paramedics, in association with Galen, the privately owned pharmaceutical sales and marketing company, is proud to announce the winner of the Dr John Hinds Scholarship Award 2020: Orla Morrow of Northern Ireland Ambulance Service, Belfast. To qualify for the scholarship, entrants were...

Read more

Self-administered pain-killer saves patient time and NHS resources in accident and emergency departments

Inhaled analgesic can save average patient 71 minutes for some common injuries compared to traditional therapies Craigavon, N.I., Tuesday 31 March 2020 - An inhaled analgesic recently introduced to the UK can save more than one hour per appropriate procedure in hospital accident and emergency (A&E) departments on average – allowing more...

Read more

Call for entries for the Dr John Hinds Scholarship

Call for entries for the Dr John Hinds Scholarship Craigavon, N.I., 3 Mar 2020 – The College of Paramedics, in association with Galen the privately owned pharmaceutical sales and marketing company, is calling on all levels of pre-hospital responders on the island of Ireland, to take part in this exciting opportunity to win a place at the much...

Read more

Launch of innovative medical food provides a palatable new option for people diagnosed with rare metabolic disorder in the UK

Launch of innovative medical food provides a palatable new option for people diagnosed with rare metabolic disorder in the UK   Craigavon, N.I., 13 Feb 2020 – An innovative medical food (food for special medical purpose) for people living with the rare, inherited metabolic disorder, phenylketonuria – or PKU as it is known for short...

Read more

Galen Announces Completion of Multi-Million Pound POA Pharma Acquisition

Move adds substantial new therapeutic areas and territories to Galen’s reach Craigavon, N.I., 8 Jan 2020 - Galen, the privately owned global pharmaceutical sales and marketing company, today announced the completion of a multi-million pound acquisition and takeover of boutique healthcare company, POA Pharma. The move enables Galen to...

Read more

Galen attends the Royal College of Emergency Medicine annual scientific meeting 2019

Galen were this year’s platinum sponsors at the Royal College of Emergency Medicine annual scientific meeting in The Sage, Gateshead. The Galen Penthrox team spent three days with some of emergency medicine’s key opinion leaders in what was a truly excellent event. Galen provided speakers Dr Chris Moulton and Dr George Bailey to discuss...

Read more

NI Chamber Puts Dr Dennise Broderick under the Spotlight

Galen President and MD first keynote speaker in CEO Spotlight Series Craigavon, N.I., 7 Oct 2019 - Dr. Dennise Broderick, President and Managing Director of global speciality pharmaceutical company, Galen, was the first member to participate in Northern Ireland Chamber of Commerce and Industry’s CEO Spotlight Series. Supported by KPMG, the...

Read more

Dr Dennise Broderick, President and Managing Director of Galen, explains her commitment to driving growth with a strong focus on the customer and the patient.

Driving growth through patient focus Dr Dennise Broderick, President and Managing Director of Galen (a member of the Almac Group), explains her commitment to driving growth with a strong focus on the customer and the patient. Article published in : www.chemicalsknowledgehub.com, June/July 2019.  Galen, a Northern Irish based...

Read more

Galen Appoints Dr Dennise Broderick as Managing Director

15th January 2019 | Galen Ltd, the Northern Ireland based pharmaceutical company, is delighted to announce the appointment of Dr Dennise Broderick as its new Managing Director and President. She will report to Alan Armstrong, CEO and Chairman, Almac Group, - the parent company of Galen Ltd. Together with Almac Group’s Board of...

Read more

Galen expands further into US with significant acquisition

11th July 2013 | Galen Ltd, the Craigavon-based pharmaceutical company that is part of Almac Group, has reached a significant deal with a US company to acquire the rights to a leading medicinal product. Galen US, Inc., a wholly owned subsidiary of Galen Ltd, has entered into a product acquisition and license agreement with Nuvo...

Read more

Galen acquires Synera

11th July 2013 | SOUDERTON, PENNSYLVANIA Galen, a Northern Ireland based pharmaceutical company, has acquired Synera® (lidocaine 70mg/tetracaine 70mg) topical patch from ZARS Pharma Inc., a wholly owned subsidiary of Nuvo Research Inc. Synera® is indicated for use on intact skin to provide local dermal analgesia for...

Read more

Would you like to discuss how Galen can help you?

If you would like to explore how Galen’s expertise could add value to your product, or for an initial discussion about partnering with us, please contact our team.